BCAL Diagnostics Ltd
BDX
Company Profile
Business description
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.
Contact
50 Clarence Street
Suite 506, Level 5
SydneyNSW2000
AUST: +61 290787671
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Picking dividend shares in 2026? Here’s where to look
A new report from Morningstar shows opportunities for income investors.
stocks
Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?
With outstanding long-term estimates, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,842.50 | 96.90 | 1.11% |
| CAC 40 | 7,953.77 | 14.16 | -0.18% |
| DAX 40 | 23,162.92 | 17.61 | -0.08% |
| Dow JONES (US) | 46,138.77 | 47.03 | 0.10% |
| FTSE 100 | 9,507.41 | 44.89 | -0.47% |
| HKSE | 25,803.44 | 27.21 | -0.11% |
| NASDAQ | 22,564.23 | 131.38 | 0.59% |
| Nikkei 225 | 50,025.10 | 1,487.40 | 3.06% |
| NZX 50 Index | 13,413.45 | 86.55 | 0.65% |
| S&P 500 | 6,642.16 | 24.84 | 0.38% |
| S&P/ASX 200 | 8,560.00 | 92.00 | 1.09% |
| SSE Composite Index | 3,953.13 | 6.39 | 0.16% |